首页> 美国卫生研究院文献>The Journal of Biological Chemistry >NF-κB and Enhancer-binding CREB Protein Scaffolded by CREB-binding Protein (CBP)/p300 Proteins Regulate CD59 Protein Expression to Protect Cells from Complement Attack
【2h】

NF-κB and Enhancer-binding CREB Protein Scaffolded by CREB-binding Protein (CBP)/p300 Proteins Regulate CD59 Protein Expression to Protect Cells from Complement Attack

机译:NF-κB和CREB结合蛋白(CBP)/ p300蛋白支撑的增强子结合CREB蛋白调节CD59蛋白表达以保护细胞免受补体攻击。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The complement system can be activated spontaneously for immune surveillance or induced to clear invading pathogens, in which the membrane attack complex (MAC, C5b-9) plays a critical role. CD59 is the sole membrane complement regulatory protein (mCRP) that restricts MAC assembly. CD59, therefore, protects innocent host cells from attacks by the complement system, and host cells require the constitutive and inducible expression of CD59 to protect themselves from deleterious destruction by complement. However, the mechanisms that underlie CD59 regulation remain largely unknown. In this study we demonstrate that the widely expressed transcription factor Sp1 may regulate the constitutive expression of CD59, whereas CREB-binding protein (CBP)/p300 bridge NF-κB and CREB, which surprisingly functions as an enhancer-binding protein to induce the up-regulation of CD59 during in lipopolysaccharide (LPS)-triggered complement activation, thus conferring host defense against further MAC-mediated destruction. Moreover, individual treatment with LPS, TNF-α, and the complement activation products (sublytic MAC (SC5b-9) and C5a) could increase the expression of CD59 mainly by activating NF-κB and CREB signaling pathways. Together, our findings identify a novel gene regulation mechanism involving CBP/p300, NF-κB, and CREB; this mechanism suggests potential drug targets for controlling various complement-related human diseases.
机译:补体系统可以自发激活以进行免疫监视或诱导清除入侵的病原体,其中膜攻击复合物(MAC,C5b-9)起着关键作用。 CD59是限制MAC装配的唯一膜补体调节蛋白(mCRP)。因此,CD59保护无辜宿主细胞免受补体系统的攻击,并且宿主细胞需要CD59的组成型和诱导型表达来保护自身免受补体的有害破坏。但是,CD59调控的基础机制仍然未知。在这项研究中,我们证明了广泛表达的转录因子Sp1可能调节CD59的组成型表达,而CREB结合蛋白(CBP)/ p300桥接NF-κB和CREB,这令人惊讶地起着增强剂结合蛋白的作用,从而诱导了CD59的上调。在脂多糖(LPS)触发的补体激活过程中调节CD59的表达,从而赋予宿主防御进一步的MAC介导的破坏的能力。此外,单独使用LPS,TNF-α和补体激活产物(分解型MAC(SC5b-9)和C5a)进行治疗,可能主要通过激活NF-κB和CREB信号通路来增加CD59的表达。总之,我们的发现确定了涉及CBP / p300,NF-κB和CREB的新型基因调控机制。该机制提示了控制各种与补体相关的人类疾病的潜在药物靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号